JNJ · Johnson & Johnson
AI read · Good for JNJ
The AI's read
The second successful late-stage study adds evidence for a planned U.S. filing. Benefits appeared by Day 3 and lasted through Week 3. Dizziness, dry mouth, and sleepiness were listed, but dropouts were low and the safety profile matched earlier results.